InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $6.765 0.015 (0.22%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4,488 Application for quotation of securities - EMR 10 Apr 2024 7:00PM $3.460 $6.765 risen by 95.52%
$4,488 Option Exercise 10 Apr 2024 6:53PM $3.460 $6.765 risen by 95.52%
$4,488 Application for quotation of securities - EMR 10 Apr 2024 6:39PM $3.460 $6.765 risen by 95.52%
$4,488 Fourth Supplementary Bidder's Statement 10 Apr 2024 9:26AM $3.500 $6.765 risen by 93.29%
$4,488 Fourth Supplementary Target's Statement 9 Apr 2024 5:49PM $3.500 $6.765 risen by 93.29%
$4,488 Okvau Continues to Deliver - Quarterly Gold Production 8 Apr 2024 8:29AM $3.330 $6.765 risen by 103.15%
$4,488 Recommended and Unconditional Takeover Offer Extended 5 Apr 2024 9:54AM $3.260 $6.765 risen by 107.52%
$4,488 Notification regarding unquoted securities - EMR 26 Mar 2024 7:35PM $2.760 $6.765 risen by 145.11%
$4,488 Third Supplementary Target's Statement 21 Mar 2024 8:26PM $2.930 $6.765 risen by 130.89%
$4,488 Third Supplementary Bidder's Statement 20 Mar 2024 7:16PM $2.780 $6.765 risen by 143.35%
$4,488 Change in substantial holding 20 Mar 2024 9:44AM $2.790 $6.765 risen by 142.47%
$4,488 New High Grade Gold Discovery - Freeman's Find Prospect 18 Mar 2024 9:42AM $2.860 $6.765 risen by 136.54%
$4,488 Recommended and Unconditional Takeover Offer Extended 15 Mar 2024 7:47PM $2.860 $6.765 risen by 136.54%
$4,488 Application for quotation of securities - EMR 12 Mar 2024 5:42PM $3.040 $6.765 risen by 122.53%
$4,488 Option Exercise 12 Mar 2024 5:41PM $3.040 $6.765 risen by 122.53%
$4,488 Notification regarding unquoted securities - EMR 4 Mar 2024 4:30PM $2.990 $6.765 risen by 126.25%
$4,488 Proposed issue of securities - EMR 4 Mar 2024 4:27PM $2.990 $6.765 risen by 126.25%
$4,488 Change in substantial holding 4 Mar 2024 12:10PM $2.980 $6.765 risen by 127.01%
$4,488 Change in substantial holding 4 Mar 2024 8:17AM $2.890 $6.765 risen by 134.08%
$4,488 Final Director's Interest Notice 1 Mar 2024 4:16PM $2.890 $6.765 risen by 134.08%
$4,488 Board and Sub-Committee Changes 1 Mar 2024 4:13PM $2.890 $6.765 risen by 134.08%
$4,488 Emerald's Growth Strategy Underpinned by Okvau Excellence 29 Feb 2024 9:11AM $2.810 $6.765 risen by 140.75%
$4,488 Half Yearly Report and Accounts 29 Feb 2024 9:00AM $2.810 $6.765 risen by 140.75%
$4,488 Recommended and Unconditional Takeover Offer Extended 20 Feb 2024 5:58PM $2.950 $6.765 risen by 129.32%
$4,488 Second Supplementary Target's Statement 15 Feb 2024 8:15AM $3.140 $6.765 risen by 115.45%

276 - 300 of 1042 results

Page 12 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.